1st Quarter - Report

DALRYMPLE & ASSOCIATES, LLC for PULMATRIX, INC.

Firm
Client
Income
$17,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Appropriations and funding under federal government contracts for development of broad spectrum products and delivery systems for the prevention, prophylaxis, treatment and halting transmission of infectious respiratory diseases.

LobbyistCovered position, as disclosed
DONALD DALRYMPLE Principal and Managing Director

Contacted: Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); Army, Dept of (Other); Defense Advanced Research Projects Agency (DARPA); HOUSE OF REPRESENTATIVES; Government Accountability Office (GAO); Natl Institutes of Health (NIH); Defense, Dept of (DOD); State, Dept of (DOS); Defense Threat Reduction Agency (DTRA); Executive Office of the President (EOP); Homeland Security, Dept of (DHS); SENATE; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.